Between 2002 and 2004, Pfizer explored green chemistry as a product, process, and strategy design approach that could address a growing set of market complexities. The case requires students to understand and analyze how and why green chemistry might contribute to corporate growth. The case elaborates on the conditions encouraging pharmaceutical companies to engage more actively on environmental and health issues as an area of opportunity as opposed to an effort toward compliance or response to competitive threat.
